Purakkattle Biju

Person

Westwood, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Compounds as indoleamine 2,3-dioxygenase inhibitors
- Patent number 10,538,497
- Issue date Jan 21, 2020
- Merck Sharp & Dohme Corp.
- Yongxin Han
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antidiabetic tricyclic compounds
- Patent number 10,519,115
- Issue date Dec 31, 2019
- Merck Sharp & Dohme Corp.
- Tesfaye Biftu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tricyclic compounds as inhibitors of mutant IDH enzymes
- Patent number 10,442,819
- Issue date Oct 15, 2019
- Merck Sharp & Dohme Corp.
- Christian Fischer
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Grant
Tricyclic compounds as inhibitors of mutant IDH enzymes
- Patent number 10,399,972
- Issue date Sep 3, 2019
- Merck Sharp & Dohme Corp.
- David J. Witter
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Aminoquinazoline compounds as A2A antagonist
- Patent number 10,138,212
- Issue date Nov 27, 2018
- Merck Sharp & Dohme Corp.
- Amjad Ali
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antidiabetic tricyclic compounds
- Patent number 10,000,454
- Issue date Jun 19, 2018
- Merck Sharp & Dohme
- Tesfaye Biftu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antidiabetic tricyclic compounds
- Patent number 9,932,311
- Issue date Apr 3, 2018
- Merck Sharp & Dohme Corp.
- Tesfaye Biftu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antidiabetic substituted heteroaryl compounds
- Patent number 9,834,563
- Issue date Dec 5, 2017
- Merck Sharp & Dohme Corp.
- William K. Hagmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antidiabetic tricyclic compounds
- Patent number 9,527,875
- Issue date Dec 27, 2016
- Merck Sharp & Dohme Corp.
- William K. Hagmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Quinoxalines and AZA-quinoxalines as CRTH2 receptor modulators
- Patent number 9,469,615
- Issue date Oct 18, 2016
- Merck Sharp & Dohme Corp.
- Christopher W. Boyce
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Quinazolinone-type compounds as CRTH2 antagonists
- Patent number 8,927,559
- Issue date Jan 6, 2015
- Merck Sharp & Dohme Corp.
- Robert G. Aslanian
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cycloalkyl-fused tetrahydroquinolines as CRTH2 receptor modulators
- Patent number 8,592,383
- Issue date Nov 26, 2013
- Merck Sharp & Dohme Corp.
- Xianhai Huang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
C20-C21 substituted glucocorticoid receptor agonists
- Patent number 8,524,697
- Issue date Sep 3, 2013
- Merck Sharp & Dohme Corp.
- John C. Anthes
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
ALPHA2C adrenoreceptor agonists
- Patent number 7,985,748
- Issue date Jul 26, 2011
- Pharmacopeia Drug Discovery, Inc.
- Kevin D. McCormick
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor...
- Patent number 7,964,646
- Issue date Jun 21, 2011
- Schering Corporation
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Treatment of chemokine mediated diseases
- Patent number 7,960,433
- Issue date Jun 14, 2011
- Schering Corporation
- Arthur G. Taveras
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor...
- Patent number 7,947,720
- Issue date May 24, 2011
- Schering Corporation
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
5,6-di-substituted oxadiazolopyrazines and thiadiazolopyrazines as...
- Patent number 7,897,606
- Issue date Mar 1, 2011
- Schering Corporation
- Purakkattle J. Biju
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Thiadiazoles as CXC- and CC- chemokine receptor ligands
- Patent number 7,786,149
- Issue date Aug 31, 2010
- Schering Corp.
- Purakkattle J. Biju
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Di-substituted oxadiazoles as CXC-chemokine receptor ligands
- Patent number 7,718,678
- Issue date May 18, 2010
- Schering Corporation
- Purakkattle J. Biju
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine...
- Patent number 7,691,856
- Issue date Apr 6, 2010
- Schering Corporation
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isothiazole dioxides as CXC- and CC-chemokine receptor ligands
- Patent number 7,671,212
- Issue date Mar 2, 2010
- Schering Corporation
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Phenoxypiperidines and analogs thereof useful as histamine H3 antag...
- Patent number 7,638,531
- Issue date Dec 29, 2009
- Schering Corporation
- Mwangi W. Mutahi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Thiadiazoles AS CXC- and CC- chemokine receptor ligands
- Patent number 7,338,968
- Issue date Mar 4, 2008
- Schering Corporation
- Purakkattle J. Biju
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor...
- Patent number 7,132,445
- Issue date Nov 7, 2006
- Schering Corporation
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
NOVEL COMPOUNDS AS INDOLEAMINE 2,3-DIOXYGENASE INHIBITORS
- Publication number 20180362482
- Publication date Dec 20, 2018
- MERCK SHARP & DOHME CORP.
- Yongxin Han
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL TRICYCLIC COMPOUNDS AS INHIBITORS OF MUTANT IDH ENZYMES
- Publication number 20180305352
- Publication date Oct 25, 2018
- MERCK SHARP & DOHME CORP.
- David J. Witter
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AMINOQUINAZOLINE COMPOUNDS AS A2A ANTAGONIST
- Publication number 20180037554
- Publication date Feb 8, 2018
- MERCK SHARP & DOHME CORP.
- Amjad Ali
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIDIABETIC SUBSTITUTED HETEROARYL COMPOUNDS
- Publication number 20170166578
- Publication date Jun 15, 2017
- MERCK SHARP & DOHME CORP.
- William K. Hagmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIDIABETIC TRICYCLIC COMPOUNDS
- Publication number 20170081287
- Publication date Mar 23, 2017
- MERCK SHARP & DOHME CORP.
- Tesfaye Biftu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIDIABETIC TRICYCLIC COMPOUNDS
- Publication number 20160257652
- Publication date Sep 8, 2016
- MERCK SHARP & DOHME CORP.
- Tesfaye Biftu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIDIABETIC TRICYCLIC COMPOUNDS
- Publication number 20160207887
- Publication date Jul 21, 2016
- MERCK SHARP & DOHME CORP.
- Tesfaye Biftu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIDIABETIC TRICYCLIC COMPOUNDS
- Publication number 20150191495
- Publication date Jul 9, 2015
- MERCK SHARP & DOHME CORP.
- William K. Hagmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CYCLOALKYL-FUSED TETRAHYDROQUINOLINES AS CRTH2 RECEPTOR MODULATORS
- Publication number 20140128367
- Publication date May 8, 2014
- MERCK SHARP & DOHME CORP.
- Xianhai Huang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIDIABETIC TRICYCLIC COMPOUNDS
- Publication number 20140045746
- Publication date Feb 13, 2014
- MERCK SHARP & DOHME CORP.
- William K. Hagmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
QUINOXALINES AND AZA-QUINOXALINES AS CRTH2 RECEPTOR MODULATORS
- Publication number 20130303517
- Publication date Nov 14, 2013
- Christopher W. Boyce
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CYCLOALKYL-FUSED TETRAHYDROQUINOLINES AS CRTH2 RECEPTOR MODULATORS
- Publication number 20120329743
- Publication date Dec 27, 2012
- Xianhai Huang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
C21 THIOETHERS AS GLUCOCORTICOID RECEPTOR AGONISTS
- Publication number 20110262368
- Publication date Oct 27, 2011
- Schering Corporation
- John C. Anthes
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3,4-Di-Substituted Cyclobutene-1,2-Diones as CXC-Chemokine Receptor...
- Publication number 20110213029
- Publication date Sep 1, 2011
- Schering Corporation
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY
Information Patent Application
C20-C21 SUBSTITUTED GLUCOCORTICOID RECEPTOR AGONISTS
- Publication number 20110182828
- Publication date Jul 28, 2011
- Schering Corporation
- John C. Anthes
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ALPHA2C ADRENORECEPTOR AGONISTS
- Publication number 20100173823
- Publication date Jul 8, 2010
- Kevin D. McCormick
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3,4-DI-SUBSTITUTED CYCLOBUTENE-1,2-DIONES AS CXC-CHEMOKINE RECEPTOR...
- Publication number 20090306079
- Publication date Dec 10, 2009
- Schering Corporation
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THIADIAZOLES AS CXC- AND CC- CHEMOKINE RECEPTOR LIGANDS
- Publication number 20080090823
- Publication date Apr 17, 2008
- Purakkattle J. Biju
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine...
- Publication number 20070264230
- Publication date Nov 15, 2007
- Schering Corporation
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Phenoxypiperidines and analogs thereof useful as histamine H3 antag...
- Publication number 20070167435
- Publication date Jul 19, 2007
- Schering Corporation
- Mwangi W. Mutahi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Treatment of chemokine mediated diseases
- Publication number 20070155756
- Publication date Jul 5, 2007
- Schering Corporation
- Arthur G. Taveras
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Alpha2C adrenoreceptor agonists
- Publication number 20070093477
- Publication date Apr 26, 2007
- Schering Corporation and Pharmacopeia Drug Discovery, Inc.
- Kevin D. McCormick
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor...
- Publication number 20070021494
- Publication date Jan 25, 2007
- Schering Corporation and Pharmacopeia, Inc.
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY
Information Patent Application
5,6-Di-substituted oxadiazolopyrazines and thiadiazolopyrazines as...
- Publication number 20070015731
- Publication date Jan 18, 2007
- Purakkattle J. Biju
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Di-substituted oxadiazoles as CXC-chemokine receptor ligands
- Publication number 20070004682
- Publication date Jan 4, 2007
- Schering Corporation
- Purakkattle J. Biju
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Thiadiazoles AS CXC- and CC- chemokine receptor ligands
- Publication number 20060223864
- Publication date Oct 5, 2006
- Schering Corporation and Pharmacopeia Drug Discovery, Inc.
- Purakkattle J. Biju
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Isothiazole dioxides as CXC- and CC-chemokine receptor ligands
- Publication number 20060025453
- Publication date Feb 2, 2006
- Schering Corporation and Pharmacopeia Drug Discovery, Inc.
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC- chemokine...
- Publication number 20040186142
- Publication date Sep 23, 2004
- Schering Corporation Pharmacopeia, Inc.
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor...
- Publication number 20040147559
- Publication date Jul 29, 2004
- Schering Corporation and Pharmacopeia, Inc.
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor...
- Publication number 20040106794
- Publication date Jun 3, 2004
- Schering Corporation
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY

Purakkattle Biju

Person

Patents Grantslast 30 patents

Compounds as indoleamine 2,3-dioxygenase inhibitors

Antidiabetic tricyclic compounds

Tricyclic compounds as inhibitors of mutant IDH enzymes

Tricyclic compounds as inhibitors of mutant IDH enzymes

Aminoquinazoline compounds as A2A antagonist

Antidiabetic tricyclic compounds

Antidiabetic tricyclic compounds

Antidiabetic substituted heteroaryl compounds

Antidiabetic tricyclic compounds

Quinoxalines and AZA-quinoxalines as CRTH2 receptor modulators

Quinazolinone-type compounds as CRTH2 antagonists

Cycloalkyl-fused tetrahydroquinolines as CRTH2 receptor modulators

C20-C21 substituted glucocorticoid receptor agonists

ALPHA2C adrenoreceptor agonists

3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor...

Treatment of chemokine mediated diseases

3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor...

5,6-di-substituted oxadiazolopyrazines and thiadiazolopyrazines as...

Thiadiazoles as CXC- and CC- chemokine receptor ligands

Di-substituted oxadiazoles as CXC-chemokine receptor ligands

Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine...

Isothiazole dioxides as CXC- and CC-chemokine receptor ligands

Phenoxypiperidines and analogs thereof useful as histamine H3 antag...

Thiadiazoles AS CXC- and CC- chemokine receptor ligands

3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor...

Patents Applicationslast 30 patents

NOVEL COMPOUNDS AS INDOLEAMINE 2,3-DIOXYGENASE INHIBITORS

NOVEL TRICYCLIC COMPOUNDS AS INHIBITORS OF MUTANT IDH ENZYMES

AMINOQUINAZOLINE COMPOUNDS AS A2A ANTAGONIST

ANTIDIABETIC SUBSTITUTED HETEROARYL COMPOUNDS

ANTIDIABETIC TRICYCLIC COMPOUNDS

ANTIDIABETIC TRICYCLIC COMPOUNDS

ANTIDIABETIC TRICYCLIC COMPOUNDS

ANTIDIABETIC TRICYCLIC COMPOUNDS

CYCLOALKYL-FUSED TETRAHYDROQUINOLINES AS CRTH2 RECEPTOR MODULATORS

ANTIDIABETIC TRICYCLIC COMPOUNDS

QUINOXALINES AND AZA-QUINOXALINES AS CRTH2 RECEPTOR MODULATORS

CYCLOALKYL-FUSED TETRAHYDROQUINOLINES AS CRTH2 RECEPTOR MODULATORS

C21 THIOETHERS AS GLUCOCORTICOID RECEPTOR AGONISTS

3,4-Di-Substituted Cyclobutene-1,2-Diones as CXC-Chemokine Receptor...

C20-C21 SUBSTITUTED GLUCOCORTICOID RECEPTOR AGONISTS

ALPHA2C ADRENORECEPTOR AGONISTS

3,4-DI-SUBSTITUTED CYCLOBUTENE-1,2-DIONES AS CXC-CHEMOKINE RECEPTOR...

THIADIAZOLES AS CXC- AND CC- CHEMOKINE RECEPTOR LIGANDS

Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine...

Phenoxypiperidines and analogs thereof useful as histamine H3 antag...

Treatment of chemokine mediated diseases

Alpha2C adrenoreceptor agonists

3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor...

5,6-Di-substituted oxadiazolopyrazines and thiadiazolopyrazines as...

Di-substituted oxadiazoles as CXC-chemokine receptor ligands

Thiadiazoles AS CXC- and CC- chemokine receptor ligands

Isothiazole dioxides as CXC- and CC-chemokine receptor ligands

Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC- chemokine...

3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor...

3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor...